2026 NPPES data Optometrist NPI 1366794638 O.D.
Verify on CMS →

MOHINDRA RAMPHAL, O.D.

Optometrist in SILVER SPRING, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
574
Medicare Part D claims · 254 beneficiaries · Optometrist avg: 257
Generic prescribing
48%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
51.3087/100
▼ 32 pts below national avg 83.1 · [object Object]
Industry payments
$782.19
32 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MOHINDRA RAMPHAL, O.D. reported a CMS MIPS final score of 51.3087/100 — below the 83.1 national average — and filed 574 Medicare Part D claims in 2023.

51.3087/100
MIPS score · -32 vs avg
574
Part D claims, 2023
48%
generic prescribing
$782.19
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MOHINDRA RAMPHAL, O.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

51 4th percentile higher than 4% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). This entry sits in this band. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about MOHINDRA RAMPHAL, O.D.?

Below national average

NPI registry status

Active

Issued 10/10/2012

NPI 1366794638

Primary specialty

Optometrist

High-volume

60,463 US NPIs in this specialty

Medicare Part D claims

574 123% vs specialty avg

2023 prescription claims

Specialty avg: 257

MIPS final score

51.3087/100 31.791299999999993% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Maryland

How Optometrist compares to other specialties among Maryland providers

Maryland providers

Optometrist share within Maryland

1. Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Optometrist share within Maryland

Medicare quality performance — MIPS

MOHINDRA RAMPHAL, O.D.'s 2023 MIPS final score plotted against the Optometrist national average

Below national average
MIPS Final Score
51.3087/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Optometrist) — 51.3087/100 vs national avg 83.1

0%100%National avg83%51.3%
MIPS final score (Optometrist) — 51.3087/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MOHINDRA RAMPHAL, O.D. appears in the CMS NPPES registry as a Optometrist provider holding O.D. credentials at 12504 GREENHILL DR, SILVER SPRING, MD, 20904, with a listed phone of (301) 602-1016. NPI 1366794638 was issued on 10/10/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RAMPHAL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 574 prescription claims written by this provider, covering 254 Medicare beneficiaries and totaling roughly $149K in drug spend, split 52% brand-name and 48% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 51.3087/100 for the 2023 performance year (Quality 100, Cost 21.029), compared with the national average of 83.1.

Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

12504 GREENHILL DR
SILVER SPRING, MD 20904

Provider Details

NPI 1366794638
Specialty Optometrist
Credentials O.D.
Gender Male
NPI Issued 10/10/2012

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

51.3087
Final Score
Avg: 83.1
100
Quality
21.029
Cost
0
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MOHINDRA RAMPHAL, O.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CHESAPEAKE EYE CARE AND LASER CENTER LLC
HAGERSTOWN, MD

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MOHINDRA RAMPHAL, O.D.. Source: openpaymentsdata.cms.gov.

Total received

$782

Largest payer

SUN PHARMACEUTICAL INDUSTRIES INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

MOHINDRA RAMPHAL, O.D. — brand share 52.0%
Specialty average (est.)

52% brand-name claims vs 48% generic, on 574 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

574
Total Claims
$149K
Total Drug Cost
254
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
988
Total Day Supply
27,848
Brand vs Generic
52% brand / 48% generic
Brand Drug Cost
$135K
Generic Drug Cost
$14K

Patient Demographics

Average Patient Age
73.8 years
Avg HCC Risk Score
1.24
Gender Split
63% female / 37% male
Age Distribution
<65: 24, 65-74: 104, 75-84: 99, 85+: 27

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MOHINDRA RAMPHAL, O.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
119
Fluorometholone
60
Loteprednol Etabonate
53
Prednisolone Acetate
44
Restasis
Cyclosporine
42
Tobramycin-Dexamethasone
Tobramycin/Dexamethasone
42
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
31
Timolol Maleate
25
Combigan
Brimonidine Tartrate/Timolol
20
Brimonidine Tartrate
19

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Optometrist Overview

How MOHINDRA RAMPHAL, O.D. fits within the Optometrist landscape nationally.

60,463
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider

MOHINDRA RAMPHAL, O.D.'s 574 claims are above the specialty average of 257.

Nearby Optometrist Providers in Maryland

Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as RAMPHAL.

Compare Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MOHINDRA RAMPHAL, O.D.'s specialty?
MOHINDRA RAMPHAL, O.D. specializes in Optometrist and practices in SILVER SPRING, Maryland. Credentials: O.D..
How much does MOHINDRA RAMPHAL, O.D. prescribe under Medicare Part D?
In 2023, MOHINDRA RAMPHAL, O.D. wrote 574 Medicare Part D claims totaling $149K in drug costs for 254 beneficiaries.
What is MOHINDRA RAMPHAL, O.D.'s Medicare quality score?
MOHINDRA RAMPHAL, O.D. has a CMS MIPS Final Score of 51.3087/100 (Quality: 100, Cost: 21.029). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MOHINDRA RAMPHAL, O.D. located?
MOHINDRA RAMPHAL, O.D. is located at 12504 GREENHILL DR, SILVER SPRING, MD, 20904. Phone: (301) 602-1016.
What is MOHINDRA RAMPHAL, O.D.'s NPI number?
MOHINDRA RAMPHAL, O.D.'s National Provider Identifier (NPI) is 1366794638, issued on 10/10/2012.
Does MOHINDRA RAMPHAL, O.D. prescribe more brand-name or generic drugs?
MOHINDRA RAMPHAL, O.D.'s prescribing is 52% brand-name and 48% generic drugs by claim count, with $135K in brand drug costs.
How many Optometrist providers are there in the US?
There are 60,463 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does MOHINDRA RAMPHAL, O.D. prescribe most often?
Based on 2023 Medicare Part D data, MOHINDRA RAMPHAL, O.D.'s most frequently prescribed drugs include Latanoprost, Fluorometholone, Loteprednol Etabonate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MOHINDRA RAMPHAL, O.D. accept Medicare?
MOHINDRA RAMPHAL, O.D. appears in CMS Medicare data with 574 Part D claims and 254 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MOHINDRA RAMPHAL, O.D.'s credentials?
MOHINDRA RAMPHAL, O.D.'s NPI is 1366794638 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology